Cellartis AB Participates In Pioneering Stem Cell Collaboration In Scotland; £9.5 Million
1/18/2007 1:14:05 PM
GOTHENBURG, Sweden--(BUSINESS WIRE)--The Gothenburg, Sweden, based biotech company Cellartis AB and its partners ITI Life Sciences and University of Glasgow today announced an extensive £9.5 million R&D programme to develop human stem cells for pharmaceutical research. The funding of the programme was made by ITI Life Sciences.
comments powered by